CLNS1A regulates genome stability and cell cycle progression to control CD4 T cell function and autoimmunity

Sci Immunol. 2025 Jun 20;10(108):eadq8860. doi: 10.1126/sciimmunol.adq8860. Epub 2025 Jun 20.

Abstract

Pathogenic CD4 T cells drive autoimmunity in diseases such as multiple sclerosis (MS) and inflammatory bowel disease (IBD). Through a forward genetic screen, we identified chloride nucleotide-sensitive channel 1A (CLNS1A) as a key regulator of inflammation in the experimental autoimmune encephalomyelitis (EAE) model of MS. CLNS1A is expressed in several subsets of CD4 T cells, including pathogenic T helper 17 (pTH17) cells. Deletion of Clns1a in T cells resulted in DNA damage, cell cycle arrest, impaired T cell proliferation, and effector function, thereby protecting mice from both EAE and IBD. We found that CLNS1A interacts with protein arginine methyl transferase 5 (PRMT5). Moreover, CLNS1A regulates symmetric histone dimethylation and the expression of genes involved in DNA repair, replication, and cell cycle progression. Thus, CLNS1A plays an important role in CD4 T cells by promoting genome stability and cell cycle progression.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autoimmunity* / immunology
  • CD4-Positive T-Lymphocytes* / immunology
  • Cell Cycle* / immunology
  • Encephalomyelitis, Autoimmune, Experimental* / genetics
  • Encephalomyelitis, Autoimmune, Experimental* / immunology
  • Genomic Instability* / immunology
  • Humans
  • Inflammatory Bowel Diseases / genetics
  • Inflammatory Bowel Diseases / immunology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout